
Neumora Therapeutics, Inc. Common Stock
USD1.61
-0.01 (-0.92%)
CEO
Paul L. Berns
IPO Date
2023-09-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.64
Prev. Close
$1.63
Day Low
$1.59
Day High
$1.67
52W Low
$0.83
52W High
$3.65
Market Cap
$0.30B
Volume
0.40M
| 16 Jun 2026 |
| Needham |
| Buy |
| Buy |
| maintain |
| 31 Mar 2026 | Guggenheim | Buy | Buy | maintain |
| 31 Mar 2026 | Needham | Buy | Buy | maintain |
| 17 Feb 2026 | William Blair | Market Perform | Outperform | upgrade |
| 1 Dec 2025 | RBC Capital | Sector Perform | Outperform | upgrade |
| 17 Nov 2025 | Stifel | Hold | Hold | maintain |
| 28 Oct 2025 | Needham | Buy | Buy | maintain |